This study investigates the molecular expression of selected CSC markers (CD44, CD24, miR590-3p, miR599, and miR339-3p) in breast carcinoma patients before and after neoadjuvant chemotherapy (NAC). The gene discussed is CD44; the disease is breast carcinoma.